These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
210 related items for PubMed ID: 15381639
1. Expression of vascular endothelial growth factor receptor-2 or Tie-2 on peripheral blood cells defines functionally competent cell populations capable of reendothelialization. Nowak G, Karrar A, Holmén C, Nava S, Uzunel M, Hultenby K, Sumitran-Holgersson S. Circulation; 2004 Dec 14; 110(24):3699-707. PubMed ID: 15381639 [Abstract] [Full Text] [Related]
2. Rosiglitazone facilitates angiogenic progenitor cell differentiation toward endothelial lineage: a new paradigm in glitazone pleiotropy. Wang CH, Ciliberti N, Li SH, Szmitko PE, Weisel RD, Fedak PW, Al-Omran M, Cherng WJ, Li RK, Stanford WL, Verma S. Circulation; 2004 Mar 23; 109(11):1392-400. PubMed ID: 14993120 [Abstract] [Full Text] [Related]
3. Late outgrowth endothelial cells derived from Wharton jelly in human umbilical cord reduce neointimal formation after vascular injury: involvement of pigment epithelium-derived factor. Wang SH, Lin SJ, Chen YH, Lin FY, Shih JC, Wu CC, Wu HL, Chen YL. Arterioscler Thromb Vasc Biol; 2009 Jun 23; 29(6):816-22. PubMed ID: 19342598 [Abstract] [Full Text] [Related]
5. Anti-VEGFR-2 scFvs for cell isolation. Single-chain antibodies recognizing the human vascular endothelial growth factor receptor-2 (VEGFR-2/flk-1) on the surface of primary endothelial cells and preselected CD34+ cells from cord blood. Böldicke T, Tesar M, Griesel C, Rohde M, Gröne HJ, Waltenberger J, Kollet O, Lapidot T, Yayon A, Weich H. Stem Cells; 2001 Sep 23; 19(1):24-36. PubMed ID: 11209088 [Abstract] [Full Text] [Related]
6. Differentiation and proliferation of endothelial progenitor cells from canine peripheral blood mononuclear cells. Wu H, Riha GM, Yang H, Li M, Yao Q, Chen C. J Surg Res; 2005 Jun 15; 126(2):193-8. PubMed ID: 15919419 [Abstract] [Full Text] [Related]
7. Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries. Kong D, Melo LG, Gnecchi M, Zhang L, Mostoslavsky G, Liew CC, Pratt RE, Dzau VJ. Circulation; 2004 Oct 05; 110(14):2039-46. PubMed ID: 15451799 [Abstract] [Full Text] [Related]
8. Shb promotes blood vessel formation in embryoid bodies by augmenting vascular endothelial growth factor receptor-2 and platelet-derived growth factor receptor-beta signaling. Rolny C, Lu L, Agren N, Nilsson I, Roe C, Webb GC, Welsh M. Exp Cell Res; 2005 Aug 15; 308(2):381-93. PubMed ID: 15919073 [Abstract] [Full Text] [Related]
9. Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy. Griese DP, Ehsan A, Melo LG, Kong D, Zhang L, Mann MJ, Pratt RE, Mulligan RC, Dzau VJ. Circulation; 2003 Nov 25; 108(21):2710-5. PubMed ID: 14597586 [Abstract] [Full Text] [Related]
10. Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) on monocytic bone marrow-derived cells in the conjunctiva. Hamrah P, Chen L, Cursiefen C, Zhang Q, Joyce NC, Dana MR. Exp Eye Res; 2004 Oct 25; 79(4):553-61. PubMed ID: 15381039 [Abstract] [Full Text] [Related]
11. Expression of vascular endothelial growth factor receptors on tumor cells in head and neck squamous cell carcinoma. Lalla RV, Boisoneau DS, Spiro JD, Kreutzer DL. Arch Otolaryngol Head Neck Surg; 2003 Aug 25; 129(8):882-8. PubMed ID: 12925349 [Abstract] [Full Text] [Related]
12. Pathway for differentiation of human embryonic stem cells to vascular cell components and their potential for vascular regeneration. Sone M, Itoh H, Yamahara K, Yamashita JK, Yurugi-Kobayashi T, Nonoguchi A, Suzuki Y, Chao TH, Sawada N, Fukunaga Y, Miyashita K, Park K, Oyamada N, Sawada N, Taura D, Tamura N, Kondo Y, Nito S, Suemori H, Nakatsuji N, Nishikawa S, Nakao K. Arterioscler Thromb Vasc Biol; 2007 Oct 25; 27(10):2127-34. PubMed ID: 17872458 [Abstract] [Full Text] [Related]
13. Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate reendothelialization as endothelial progenitor cells. Fujiyama S, Amano K, Uehira K, Yoshida M, Nishiwaki Y, Nozawa Y, Jin D, Takai S, Miyazaki M, Egashira K, Imada T, Iwasaka T, Matsubara H. Circ Res; 2003 Nov 14; 93(10):980-9. PubMed ID: 14525810 [Abstract] [Full Text] [Related]
14. Angiogenesis in systemic sclerosis: impaired expression of vascular endothelial growth factor receptor 1 in endothelial progenitor-derived cells under hypoxic conditions. Avouac J, Wipff J, Goldman O, Ruiz B, Couraud PO, Chiocchia G, Kahan A, Boileau C, Uzan G, Allanore Y. Arthritis Rheum; 2008 Nov 14; 58(11):3550-61. PubMed ID: 18975312 [Abstract] [Full Text] [Related]
15. Lentiviral rescue of vascular endothelial growth factor receptor-2 expression in flk1-/- embryonic stem cells shows early priming of endothelial precursors. Li X, Edholm D, Lanner F, Breier G, Farnebo F, Dimberg A, Claesson-Welsh L. Stem Cells; 2007 Dec 14; 25(12):2987-95. PubMed ID: 17702981 [Abstract] [Full Text] [Related]
16. Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growth. Ebos JM, Lee CR, Bogdanovic E, Alami J, Van Slyke P, Francia G, Xu P, Mutsaers AJ, Dumont DJ, Kerbel RS. Cancer Res; 2008 Jan 15; 68(2):521-9. PubMed ID: 18199548 [Abstract] [Full Text] [Related]
17. Establishment and characterization of conditionally immortalized endothelial cell lines from the thoracic duct and inferior vena cava of tsA58/EGFP double-transgenic rats. Matsuo M, Koizumi K, Yamada S, Tomi M, Takahashi R, Ueda M, Terasaki T, Obinata M, Hosoya K, Ohtani O, Saiki I. Cell Tissue Res; 2006 Dec 15; 326(3):749-58. PubMed ID: 16773315 [Abstract] [Full Text] [Related]
18. Only a specific subset of human peripheral-blood monocytes has endothelial-like functional capacity. Elsheikh E, Uzunel M, He Z, Holgersson J, Nowak G, Sumitran-Holgersson S. Blood; 2005 Oct 01; 106(7):2347-55. PubMed ID: 15985545 [Abstract] [Full Text] [Related]
19. VEGFR-1 and -2 regulate inflammation, myocardial angiogenesis, and arteriosclerosis in chronically rejecting cardiac allografts. Raisky O, Nykänen AI, Krebs R, Hollmén M, Keränen MA, Tikkanen JM, Sihvola R, Alhonen L, Salven P, Wu Y, Hicklin DJ, Alitalo K, Koskinen PK, Lemström KB. Arterioscler Thromb Vasc Biol; 2007 Apr 01; 27(4):819-25. PubMed ID: 17290032 [Abstract] [Full Text] [Related]
20. mTOR inhibitor RAD001 (everolimus) has antiangiogenic/vascular properties distinct from a VEGFR tyrosine kinase inhibitor. Lane HA, Wood JM, McSheehy PM, Allegrini PR, Boulay A, Brueggen J, Littlewood-Evans A, Maira SM, Martiny-Baron G, Schnell CR, Sini P, O'Reilly T. Clin Cancer Res; 2009 Mar 01; 15(5):1612-22. PubMed ID: 19223496 [Abstract] [Full Text] [Related] Page: [Next] [New Search]